218 filings
8-K
LLY
Lilly(Eli) & Co
9 Feb 24
Other Events
11:56am
8-K
LLY
Lilly(Eli) & Co
6 Feb 24
Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance
7:04am
8-K
LLY
Lilly(Eli) & Co
2 Nov 23
Lilly Reports Third-Quarter 2023 Financial Results, Highlights Strong Sales Growth and Business Development Activity
7:02am
8-K
LLY
Lilly(Eli) & Co
8 Aug 23
Lilly Reports Second-Quarter 2023 Financial Results, Highlights Accelerating Revenue Growth and Key Pipeline Advancements
7:01am
8-K
LLY
Lilly(Eli) & Co
4 May 23
Submission of Matters to a Vote of Security Holders
4:33pm
8-K
i2h8 vibz
27 Apr 23
Results of Operations and Financial Condition
7:02am
8-K
rk73ksm0
17 Mar 23
Departure of Directors or Certain Officers
4:05pm
8-K
51j8p543b
24 Feb 23
Other Events
5:00pm
8-K
324vouusplyfpuct5
2 Feb 23
Lilly Reports Fourth-Quarter 2022 Financial Results, Core Business Growth and Pipeline Advancements Support Strong Long-Term Outlook
7:13am
8-K
6nhiye3w2a
13 Dec 22
Lilly Announces 2023 Financial Guidance, Plans to Launch up to Four New Medicines
7:03am
8-K
67r rj0g0
1 Nov 22
Lilly Reports Solid Third-Quarter 2022 Financial Results and Continued Pipeline Progress
7:03am
8-K
bltazmtr
12 Oct 22
Other Events
4:08pm
8-K
lnlens keq
4 Aug 22
Lilly Reports Second-Quarter Financial Results, Highlights Momentum of New Medicines and Pipeline Advancements
7:05am
8-K
wv3tfw6rv4qzzgr2zn
6 May 22
Mary Lynne Hedley Elected to Lilly Board of Directors
4:23pm
8-K
mutk7yz6 2hdd3qk2m
4 May 22
Material Modifications to Rights of Security Holders
3:04pm
8-K
fpw776hem
28 Apr 22
Solid First-Quarter Financial Results Reflect Lilly's Continued Momentum into 2022
7:05am
8-K
fs80v4f9
14 Apr 22
Results of Operations and Financial Condition
4:57pm
8-K
wtk3 eg2us
3 Feb 22
Results of Operations and Financial Condition
7:08am
8-K
nmhex4xpx7 9aahkuwd
31 Jan 22
Other Events
8:27am
8-K
8ihn6zqw
16 Dec 21
Amendments to Articles of Incorporation or Bylaws
4:04pm